The fifth annual meeting of the Buruli ulcer PCR laboratories (BU-LABNET) network at Noguchi Memorial Institute marked a pivotal moment in addressing Buruli ulcer and skin NTDs.

Transitioning to Skin NTD LABNET signified an expanded collaborative focus in the WHO African Region.

This will help enhance skin disease diagnosis, management, and health access in endemic regions.

BU-LABNET was formed in 2019 under WHO.

The BU-LABNET unites 13 labs across nine countries to advance Buruli ulcer diagnosis using standardized PCR protocols.

They are supported by global organizations with a broader aim, encompassing skin NTDs for cost-effective, quality diagnosis expansion.

Recommendations for BU-LABNET include:

National programs are advised to do the following:

Partners were urged to support integration goals, assist in sample collection, and identify funding sources.

BU-LABNET envisions expanding its molecular platform to include additional skin NTDs and laboratories.

Thereby optimizing cost–effectiveness and increasing access to quality-assured diagnosis.